Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × camrelizumab × Clear all

NCT05981001 2023-08-08

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms